The development of effective antimicrobial treatments is one of the major advances of modern medicine. Today, the emergence and spread of antimicrobial resistance (AMR) has far reaching consequences for medical procedures and treatments, with many common drugs and interventions potentially rendered ineffective. It is estimated that 700,000 people die across the world every year due to the resistance to treatment of infections including bacterial infections, malaria, HIV/AIDS, fungal infections and tuberculosis.
A recent economic review (O’Neill report) concluded that without strategies to stop the current spread of AMR, the number of people dying from it will reach 10 million per year by 2050.
Considering the severity of the situation, the UN General Assembly convened a one-day high-level meeting at the UN Headquarters in New York on 21 September 2016. Meanwhile, the World Health Organisation has launched the Global Antimicrobial Resistance Surveillance System (GLASS) initiative in order to strengthen bacteriology laboratories in low-and middle income countries for targeted antibiotic resistance surveillance.
In addition, the use of insecticides to control vectors populations, in particular mosquitoes, remains a key measure for public health. Unfortunately, following years of intensive usage, the emergence of resistance jeopardizes the success of these control strategies worldwide.
Considering the threat that microbes and vectors resistance represent at the global scale, the Institut Pasteur has decided to focus the 4th edition of the Institut Pasteur International Network Symposium on these major issues.
It will in particular bring together scientists, clinicians and public health experts to :